Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Prescribing Analysis and Cost (PACT)
A national data set recording the cost of volume of prescriptions given by GPs. This is used to monitor and control prescribing cost and to set prescribing budgets.
At individual practitioner level, it is used as an educational and audit tool. The Prescription Pricing Authority (PPA) has sent general practitioners (GPs) quarterly summary reports of their own prescribing since 1988.
See also:
The Prescription Pricing Authority (PPA)
Prescription only medicine (POM)
Cost-effective (healthcare economics)
Cost-effectiveness league table (healthcare economics)
Related terms
Regression analysis, Environmental set, Discounted cash flow (DCF), Boston matrix, Cost-minimisation analysis (CMA), Performance prism, Sensitivity analysis (pharmacoeconomics), Payment by results (PBR) , List price, Drug usage/utilisation review (DUR), Competitors, Pharmaceutical Pricing Regulation Scheme (PPRS), Reimbursement, Baseline, Geo-demographics,
COVID-19 Updates and Daily News
Featured jobs
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- UK trial of fourth vaccine dose shows increased protection against COVID-19
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- Roche reinforces commitment to the World Federation of Hemophilia Humanitarian Aid Program
- Biogen and MedRhythms sign deal worth over $120m for digital therapeutics for MS patients
- BMA appoints two internal candidates to share the role of chief executive officer
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- FREE Live Webinar - Accelerating Patient recruitment in Clinical Trials post COVID-19 - 8th June 2022
- Phase 3 trial of AstraZeneca and Avillion’s PT027 shows promise for asthma patients
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- Roche shares new positive Ocrevus data for MS patients
- First trial of a vaccine against Alzheimer’s launches
- David Hunt launches independent agency The Considered
- Biogen and Eisai announce FDA submission for early Alzheimer’s treatment
- MHRA approves Infex Therapeutics’s study for treatment for non-cystic fibrosis patients
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
